Skip to content
Screener

908 Devices MASS G&A

G&A at other companies

Insight Molecular Diagnostics Inc. logo
Insight Molecular Diagnostics Inc.IMDX
$2.87M+8.5%

Segments

By segment

See full
Single Reportable$6.23M+6.5%

Other financials

Income statement

See full
Revenue$16.1M+23.3%
Gross profit$8.3M+30.9%
Operating income-$12.8M+15.5%
Net income-$11.9M+10.6%
EPS (diluted)-$0.32+13.5%

Balance sheet

See full
Cash & equivalents$63.0M+2.1%
Total debt$4.3M-3.0%
Total equity$126.8M-14.8%
Total assets$197.5M+3.0%

Cash flow

See full
Operating cash flow$3.2M+155%
CapEx$162.0K+32.8%
Free cash flow$3.0M+151%

Valuation

See full
Market cap$361.04M+55.6%
Enterprise value$302.32M+73.0%
P/S5.9×+1.6×

Profitability

See full
Gross margin52.2%+3.0pp
Operating margin-69.1%-21.4pp
Net margin-57%+109pp
FCF margin-1.2%-0.6pp

Returns & leverage

See full
Return on equity-25.2%-336pp
Debt / equity0×0.0×
Current ratio2.7×-2.3×

FAQ

What does G&A mean?
Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.